Dongbo Chen
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Immune Cell Function and Interaction
Papers in
-
- Pluripotent Stem Cells Research 4
- Oncology 16
- Cancer Immunotherapy and Biomarkers 6
- Co-authors
- Hongsong Chen (15 shared papers)Baoqing Wang (1 shared paper)Lansheng Zhang (1 shared paper)Pu Chen (5 shared papers)Shaoping She (4 shared papers)Ying Wang (1 shared paper)Mingyang Wang (1 shared paper)Bing Liu (3 shared papers)
- Journals
- Fish & Shellfish Immunology (4 papers)Frontiers in Oncology (3 papers)Scientific Reports (2 papers)Frontiers in Immunology (2 papers)Cancer Medicine (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Dongbo Chen
62 papers receiving 739 citations
Peers
Comparison fields: 5 of 116
- Hepatology 75
- Immunology 131
- Cancer Research 88
- Cell Biology 90
- Oncology 145
Countries citing papers authored by Dongbo Chen
This map shows the geographic impact of Dongbo Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongbo Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongbo Chen more than expected).
Fields of papers citing papers by Dongbo Chen
This network shows the impact of papers produced by Dongbo Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongbo Chen. The network helps show where Dongbo Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Dongbo Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 84 | |
| 2 | 2022 | 79 | |
| 3 | 2012 | 64 | |
| 4 | 2017 | 39 | |
| 5 | 2010 | 32 | |
| 6 | 2008 | 28 | |
| 7 | 2015 | 27 | |
| 8 | Genome-scale CRISPR activation screening identifies a role of ELAVL2-CDKN1A axis in paclitaxel resistance in esophageal squamous cell carcinoma. | 2019 | 24 |
| 9 | 2023 | 24 | |
| 10 | 2020 | 22 | |
| 11 | 2020 | 22 | |
| 12 | 2007 | 21 | |
| 13 | 2019 | 19 | |
| 14 | 2017 | 18 | |
| 15 | 2015 | 17 | |
| 16 | 2022 | 17 | |
| 17 | 2021 | 15 | |
| 18 | 2007 | 15 | |
| 19 | 2024 | 12 | |
| 20 | 2017 | 12 |
About Dongbo Chen
Dongbo Chen is a scholar working on Molecular Biology, Oncology, Surgery, Epidemiology and Hepatology, having authored 69 papers that have together received 748 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Liver Disease Diagnosis and Treatment (5 papers), Esophageal Cancer Research and Treatment (4 papers), Gastric Cancer Management and Outcomes (4 papers), Immunotherapy and Immune Responses (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Pluripotent Stem Cells Research (4 papers). The work is most often cited by research in Hepatology (75 citations), Immunology (131 citations), Cancer Research (88 citations), Cell Biology (90 citations) and Oncology (145 citations). Dongbo Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Hongsong Chen, Baoqing Wang, Lansheng Zhang, Pu Chen, Shaoping She, Ying Wang, Mingyang Wang, Bing Liu, Haibo Du and Lu Wang. Their work appears in journals such as Fish & Shellfish Immunology, Frontiers in Oncology, Scientific Reports, Frontiers in Immunology and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.